Moving a patient between hospitals during acute leukaemia treatment is a clinical transfer, not simply a transport booking. The sending and receiving doctors need to agree why the move is needed, what care must continue during it and which team will accept responsibility on arrival. An invitation to attend a consultation is not the same as acceptance for inpatient treatment.
The plan should name the receiving hospital, department and responsible clinician, with an agreed route for arrival. A family should not have to discover at the airport that the proposed appointment is outpatient while the patient still needs hospital care. Ask the current doctor to describe the required level of support and the receiving service to confirm that it can provide it.
For a critically ill patient, specialist transfer guidance emphasises risk assessment, appropriately trained accompanying staff, equipment and formal documentation. Those principles do not mean that every patient with leukaemia needs the same vehicle or escort. The transport requirements come from the patient’s present condition and the clinical assessment.
A discharge summary from the original diagnosis is useful background, but cannot describe a new infection, a recent complication or the treatment currently being given. The sending team should provide a current handover alongside the earlier diagnostic reports. Mark when it was updated so that the receiving team knows which information is current.
Ask the doctors to include the treatment phase, recent medicines and their timing, current support, allergies, important complications and results still pending. If blood products have been required, the clinical team should pass on the relevant transfusion information and any specific requirements. The family should not try to reconstruct a clinical handover from a list of pharmacy receipts.
“The flight is short” leaves out travel to the airport, waiting, border formalities and transport to the ward. Ask how the team has considered the whole interval away from the current hospital, including a delay or diversion. Which professional will be contacted if the condition changes before departure? Who decides whether the planned transfer should still go ahead?
Medicines and monitoring during the journey must follow the clinicians’ written instructions. Do not change infusion schedules, disconnect equipment or substitute a family member for a required medical escort to make a booking easier. Where commercial travel is proposed, the transport provider’s processes and clinical requirements also need to be settled before departure.
For a proposed transfer to Turkey, request a clear description of the receiving care and its anticipated financial scope. Record what has actually been confirmed and what remains provisional. A paid reservation cannot establish that a bed, a particular treatment or a medically appropriate transfer has been accepted.
The family’s useful role is to keep contact details, originals and translated summaries organised, and to make sure each team knows how to reach the other. Our guide to connecting the teams responsible for follow-up explains how to identify responsibilities across countries. It does not replace the receiving doctor’s acceptance or the sending team’s assessment.
Before leaving, the patient or accompanying person should know where arrival is expected and whom to contact if the plan changes. Necessary treatment should continue while the transfer is being organised. If the patient deteriorates, tell the current team immediately; do not proceed because tickets have already been purchased.
Medicina Turkey patient information. General guidance; individual medical decisions should be discussed with the treating clinician.